RXRX
NASDAQ · Biotechnology
Recursion Pharmaceuticals-A
$3.16
-0.02 (-0.63%)
RXRX News3 articles
Recursion Stock Surges Ahead of Goldman Sachs Conference Amid AI Drug Discovery Buzz
Recursion shares surged 12% to $3.87 on heavy volume ahead of a Goldman Sachs conference, as investors await updates on clinical trials, cash runway, and partnerships amid a broader AI drug-discovery rally.
Recursion Pharmaceuticals Hits New Low Amid Revenue Drop and FDA Watch
Recursion Pharmaceuticals shares fell to a 52-week low Tuesday after Q1 revenue dropped 56% year-over-year. The AI-driven biotech firm awaits FDA feedback on key trials.
Recursion Pharma Co-Founder Gibson to Exit Board Ahead of Q1 Results
Recursion Pharmaceuticals founder Chris Gibson will leave the board at the June annual meeting. Q1 earnings due May 6; focus on cash, clinical progress, and AI platform.